2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 86.945 | 108.879 | 119.735 | 133.742 | 139.681 | 128.013 | 20.393 | 0 | 0 | 0 |
Total Income - EUR | 88.203 | 110.980 | 122.270 | 134.380 | 140.324 | 129.007 | 20.505 | 0 | 0 | 0 |
Total Expenses - EUR | 69.721 | 92.758 | 98.214 | 102.734 | 110.855 | 114.651 | 40.910 | 6.269 | 6.880 | 4.894 |
Gross Profit/Loss - EUR | 18.482 | 18.222 | 24.056 | 31.646 | 29.469 | 14.356 | -20.405 | -6.269 | -6.880 | -4.894 |
Net Profit/Loss - EUR | 15.416 | 15.220 | 22.295 | 30.149 | 28.066 | 13.066 | -20.610 | -6.269 | -6.880 | -4.894 |
Employees | 4 | 5 | 5 | 5 | 5 | 5 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Diagnotest S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 16.445 | 22.137 | 47.112 | 46.857 | 41.703 | 40.976 | 35.561 | 30.237 | 25.860 | 21.704 |
Current Assets | 49.177 | 56.315 | 57.002 | 57.865 | 48.568 | 55.181 | 20.039 | 3.846 | 1.405 | 1.972 |
Inventories | 9.852 | 13.281 | 5.054 | 366 | 1.595 | 352 | 364 | 356 | 357 | 356 |
Receivables | 23.174 | 23.948 | 23.967 | 23.246 | 24.810 | 28.004 | 1.333 | 1.303 | 1.313 | 1.128 |
Cash | 16.152 | 19.085 | 27.981 | 34.253 | 22.163 | 26.825 | 18.342 | 2.186 | -265 | 488 |
Shareholders Funds | 40.701 | 56.260 | 68.629 | 83.244 | 73.316 | 76.535 | 46.204 | 26.782 | 19.984 | 14.849 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 24.922 | 22.192 | 35.486 | 21.478 | 16.955 | 19.622 | 9.396 | 7.301 | 7.280 | 8.827 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8690 - 8690" | |||||||||
CAEN Financial Year |
8690
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Diagnotest S.r.l.